Growth hormone replacement in patients with Langerhan's cell histiocytosis

Archives of Disease in Childhood

Volumn 78, Issue 5, 1998, Pages 469-473

  Howell, S J ^a   Wilton, P ^b   Shalet, S M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b PFIZER INC   (United States)

Author keywords

Growth hormone replacement; Langerhan's cell histiocytosis; Pituitary gland

Indexed keywords

HUMAN GROWTH HORMONE; SOMATREM;

ADULT; ARTICLE; ATAXIA; BODY HEIGHT; DRUG SAFETY; FEMALE; GERM CELL TUMOR; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HISTIOCYTOSIS; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHYROIDISM; INTRACRANIAL HYPERTENSION; LANGERHANS CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK;

EID: 0031809231     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.78.5.469     Document Type: Article

References (17)

1. Willman CL, Busque L, Griffith BB, et al. Langerhans' cell histiocytosis (histiocytosis X) - a clonal proliferative disease. N Engl J Med 1994;331:154-60.
2. Dunger DB, Broadbent V, Yeoman E, et al. The frequency and natural history of diabetes insipidus in children with Langerhans cell histiocytosis. N Engl J Med 1989;321: 1157-62.
3. Sims DG. Histiocytosis X; follow-up of 43 cases. Arch Dis Child 1977;52:433-40.
4. Grois N, Flucher-Wolfram B, Heitger A, Mostbeck GH, Hofmann J, Gadner H. Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study. Med Pediatr Oncol 1995;24:248-56.
5. The French Langerhan's Cell Histiocytosis Study Group. A multicentre retrospective survey of Langerhan's cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 1996;75;17-24.
6. Broadbent V, Dunger DB, Yeomans E, Kendall B. Anterior pituitary function and computed tomography/magnetic resonance imaging in patients with Langerhans cell histiocytosis and diabetes insipidus. Med Pediatr Oncol 1993;21: 649-54.
7. Kilpatrick SE, Wenger DE, Gilchrist GS, Shiyes TC, Wollan PC, Unni KK. Langerhan's cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 paediatric and adult cases. Cancer 1995;76:2471-84.
8. Braunstein GD, Raiti S, Hansen JW, Kohler PO. Response of growth-retarded patients with Hand-Schuller-Christian disease to growth hormone therapy. N Engl J Med 1975;292:332-3.
9. Dean HJ, Bishop A, Winter JS. Growth hormone deficiency in patients with histiocytosis X. J Pediatr 1986;109:615-18.
10. Van den Hoek AC, Karstens A, Egeler RM, Hahlen K. Growth of children with Langerhans cell histiocytosis. Eur J Pediatr 1995;154:822-5.
11. Ranke MB, Guilbaud O. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia international growth study. Acta Paediatr Scand Suppl 1991;379:109-16.
12. Clayton PE, Shalet SM, Price DA. Growth hormone treatment in children with CNS malignancy. In: Ranke MB, Gunnarsson R, eds. Progress in growth hormone therapy - 5 years of KIGS. Mannheim: J and J Verlag, 1994:157-89.
13. Price OA, Clayton PE. Growth hormone treatment in children in remission from leukaemia. In: Ranke MB, Gunnarsson R, eds. Progress in growth hormone therapy - 5 years of KIGS. Mannheim: J and J Verlag, 1994:157-89.
14. Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 study group. Med Pediatr Oncol 1994;23:72-80.
15. Malozowski S, Tanner LA, Wysowski DK, Fleming GA, Stadel BV. Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J Pediatr 1995;126:996-9.
16. Blethen SL, Allen DB, Graves D, August G, Moshang T, Rosenfeld R, on behalf of the national cooperative. Safety of recombinant deoxyribonucleic acid-derived growth hormone: the national cooperative growth study experience. J Clin Endocrinol Metab 1996;81:1704-10.
17. Wilton P. Adverse events during growth hormone treatment: 5 years experience in the Kabi International growth study. In: Ranke MB, Gunnarsson R, eds. Progress in growth hormone therapy - 5 years of KIGS. Mannheim: J and J, 1994:291-307.